SCHEMBL22894201

SCHEMBL22894201

Clc1nc(-c2ccccc2)nc(-c2cc3ccccc3c3c2sc2ccccc23)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 1/20 0.34
▸ TNKS O95271 2/20 0.33
▸ TNKS2 Q9H2K2 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ CTDSP1 Q9GZU7 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MCL1 Q07820 1/20 0.32
▸ ADORA2A P29274 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21861129 0.87 MEN1 (0.36) TNKSTNKS2MEN1KMT2AL3MBTL1
SCHEMBL20871717 0.83 LIMK1 (0.37) ADORA2AADORA1ALOX5
SCHEMBL22894200 0.82 MEN1 (0.50) EGLN1TNKSTNKS2MEN1KMT2A
SCHEMBL14882844 0.82 TNKS (0.37) TNKSTNKS2MEN1KMT2AL3MBTL1
SCHEMBL22403703 0.81 MAPK1 (0.33) MEN1KMT2AHTTL3MBTL1ALDH1A1
SCHEMBL19197073 0.81 MEN1 (0.42) TNKSTNKS2MEN1KMT2AHTT
SCHEMBL22893943 0.81 KDM4E (0.32) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL27361607 0.81 LIMK1 (0.36) TNKSTNKS2MEN1KMT2AL3MBTL1
SCHEMBL22073884 0.81 TNKS (0.41) TNKSTNKS2MEN1KMT2AHTT
SCHEMBL22073887 0.81 ALDH1A1 (0.36) MEN1KMT2AHTTL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220069233-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO.,LTD. (KR) 2022-03-03 — — US disclosed
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2021-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220069233-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OR10J3, OR51E2, AOX1 EGLN1 4760/4885TNKS 4604/4885TNKS2 4612/4885
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 EGLN1 2613/4885TNKS 2898/4885TNKS2 3488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback